HLF and Parkinson disease: In the MPTP mice, the level of IBA1 was significantly increased compared with the controls (p < 0.05, Fig. 3C, E), and the expression level of IBA1 was significantly decreased after hLf treatment in the PD model mice (p < 0.05, Fig. 3C, E).